With a flexible approach to your needs, the advisors at McKesson are here to clear the path, with resources, tools and customized consulting services. Our experts have years of experience and understand what you’re up against. We help your specialty practice increase operational efficiency, enhance financial health, transform your business for value-based care and achieve clinical excellence. Plus, we deliver clinical education and resources to help your practice successfully adopt biosimilars, better understand drug economics and improve clinical operations.
Resource
Biosimilar Master Class
Dr. Robert Rifkin and a team of expert clinical specialists and business advisors help you understand biosimilars from the U.S. Food and Drug Administration (FDA) perspective. While similar to biologic reference products, biosimilars have unique operational, clinical, and financial decision points critical to successfully implementing these therapies in your practice.
